Biological reagents

Ended Purchase Order Awarded Last action

Contract number
75N91024P00487
Awardee
Awarding agency
Obligated
$17,354

Award facts

Contract value 100% obligated
$17,354.17 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
San Diego, CA 92121, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 $144
Original award $17,210

About this award

This is a $17,354.17 firm fixed price purchase order contract awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to Invivoscribe, Inc. for the provision of biological reagents. The contract has an ultimate completion date of September 28, 2024. Invivoscribe, a for-profit manufacturer of precision diagnostics, will provide biological reagents, kits, assays, and other molecular diagnostics products to support the NCI's cancer research initiatives, including advancing the understanding of tumor biology, developing new cancer treatments, and disseminating health information. The contract does not utilize any set-aside designations. Invivoscribe has a long history of securing similar firm fixed price purchase orders from the NCI to support its cancer research program.

Quick answers

Who was awarded contract 75N91024P00487?

75N91024P00487 was awarded to Invivoscribe, Inc. by National Cancer Institute (National Institutes of Health) on June 7, 2024.

How much is contract 75N91024P00487 worth?

The government has obligated $17,354 on 75N91024P00487.

Was contract 75N91024P00487 competed?

The extent of competition for 75N91024P00487 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award